Navigation Links
deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Date:10/3/2008

s on Form 8-K. deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.

Contacts:

Edward Farmer Joy Bessenger

+1 646 417 4555 +1 212 481 3891

edward.farmer@decode.is joy.bessenger@decode.is

Gisli Arnason

+354 570 1825

gisli.arnason@decode.is


'/>"/>
SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
2. deCODE and SGENE Consortium Discover Deletions in the Human Genome Linked to Risk of Schizophrenia
3. Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
4. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
5. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
6. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
7. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
8. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
9. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
10. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
11. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Millstone Medical Outsourcing Appoints New Leadership of Memphis Facility 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 1BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 4Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 1Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 2Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 3CBI Hosts Life Sciences Summit on International Trade Compliance 14047 1CBI Hosts Life Sciences Summit on International Trade Compliance 14047 2
Breaking Medicine News(10 mins):Health News:Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 3Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 2Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 3Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 2Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 3Health News:States Slash Funding for Tobacco Prevention Programs 2Health News:States Slash Funding for Tobacco Prevention Programs 3